Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
750
NCT00487656
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2007
Completion: Aug 31, 2010